Medineutrina Private Limited
Pharmaceutical company specializing in manufacturing, packaging, and selling various healthcare products.
2014 | Nagpur, Maharashtra (India) | Active
Medineutrina Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.00 M
- Revenue Growth %
- Profit Growth -1642.22%
- Ebitda -1400.00%
- Net Worth -38.24%
- Total Assets 24.67%
About Medineutrina
Medineutrina Private Limited (MPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 August 2014 and has a history of Ten years and six months. Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.00 M.
Shila Kshirsagar and Dilipkumar Bora serve as directors at the Company.
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51900MH2014PTC256947
- Company No.
256947
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Aug 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Who are the key members and board of directors at Medineutrina?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shila Kshirsagar  | Director | 28-Apr-2021 | Current |
| Dilipkumar Bora | Director | 01-Oct-2015 | Current |
Financial Performance of Medineutrina.
Medineutrina Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 1642.22% decrease in profit. The company's net worth observed a substantial decline by a decrease of 38.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medineutrina?
In 2023, Medineutrina had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Flo Equipment Private Limited
Shila Kshirsagar is a mutual person
Charges (Loans)
Open Charges
₹7.00 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 0.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2017 | Others | ₹5.00 M | Open |
| 29 Mar 2017 | Others | ₹2.00 M | Open |
How Many Employees Work at Medineutrina?
Unlock and access historical data on people associated with Medineutrina, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medineutrina, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medineutrina's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
